Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents

Epilepsy Research

Volumn 24, Issue 2, 1996, Pages 91-100

  Kirkby, R Duncan ^a   Carroll, David M ^a   Grossman, Andrew B ^a   Subramaniam, Swaminathan ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b DR REDDY S RESEARCH FOUNDATION   (India)

Author keywords

7 Nitroindozole; GABA; Kainate; N( ) Nitroarginine L methyl ester; Picrotoxin; Seizure; Strain difference

Indexed keywords

7 NITROINDAZOLE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANTICONVULSANT THERAPY; ARTICLE; DRUG EFFECT; EPILEPSY; GENETIC VARIABILITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; STRAIN DIFFERENCE;

EID: 0029945203     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-1211(96)00005-8     Document Type: Article

References (29)

1. ω-nitro-L-arginine methyl ester, Eur. J. Pharmacol., 213 (1992) 301-304.
2. Buisson, A., Lakhmeche, N., Verrecchia, C., Plotkine, M. and Boulu, R.G., Nitric oxide: an endogenous anticonvulsant, NeuroReport, 4 (1993) 444-446.
3. G-Nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists, Circ. Res., 72 (1993) 387-395.
4. Dawson, V.L., Dawson, T.L, London, E.D., Bredt, D.H. and Snyder, S.H., Nitric oxide mediates glutamate toxicity in primary cortical cultures, Proc. Natl. Acad. Sci. USA, 88 (1991) 6368-6371.
5. De Sarro, G.B., Donato Di Paola, E., De Sarro, A. and Vidal, M.J., Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex, Fund. Clin. Pharmacol., 5 (1991) 503-511.
6. De Sarro, G.B., Donato Di Paola, E., De Sarro, A. and Vidal, M.J., L-Arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex, Eur. J. Pharmacol., 230 (1993) 151-158.
7. Golden, G.T., Smith, G.G., Ferraro, T.N., Reyes, P.F., Kulp, J.K. and Fariello, R.G., Strain differences in convulsive responses to the excitotoxin kainic acid, NeuroReport, 2 (1991) 141-144.
8. Grooms, S.Y. and Jones, L.S., Hippocampal in vitro kindling is not blocked by nitirc oxide synthase inhibitors, NeuroReport, 5 (1994) 1102-1104.
9. Haberny, K.A., Pou, S. and Eccles, C.U., Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis, Neurosci. Lett., 146 (1992) 187-190.
10. Herberg, L.H, Grottick, A. and Rose, I.C., Nitric oxide synthesis, epileptic seizures and kindling, Psychopharmacology, 119 (1995) 115-123.
11. Iadecola, C., Bietz, A.J., Renno, W., Xu, X., Mayer, B. and Zhang, F., Nitric oxide synthase-containing neural processes on large cerebral arteries and cerebral microvessels, Brain Res., 606 (1993) 184-155.
12. Kelly, P.A.T., Ritchie, I.M. and Arbuthnitt, G.W., 7-Nitro indazole uncouples cerebral blood flow from metabolic demand in the conscious rat. Br. J. Pharmacol., 112 (1994) 348P.
13. Kirkby, R.D., Forbes, R.A. and Subramaniam, S., Modification of kainate-induced behavioral and electrographic seizures following inhibition of nitric oxide synthase in mice, Epilepsy Res., 24 (1996) 79-90.
14. Manzoni, O., Prezeau, L., Deshager, S., Sahuquet, A., Sladeczek, F., Bockaert, J.L. and Fagni, L., Sodium nitroprusside blocks NMDA receptors via formation of ferrocyanide ions, NeuroReport, 3 (1992) 77-80.
15. Manzoni, O., Prezeau, L., Marin, P., Deshager, S., Bockaert, J.L. and Fagni, L., Nitric oxide-induced blockade of NMDA receptors, Neuron, 8 (1992) 653-662.
16. Mollace, V., Bagetta, G. and Nistico, G., Evidence that L-arginine possesses proconvulsant effects mediated through nitric oxide, NeuroReport, 2 (1991) 269-272.
17. Moore., P.K., Babbedge, R.C., Wallace, P., Gaffen, Z.A. and Hart, S.L., 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure, Br. J. Pharmacol., 108 (1991) 296-297.
18. Moore., P.K., Wallace, P., Gaffen, Z., Hart, S.L. and Babbedge, R.C., Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects, Br. J. Pharmacol., 110 (1993) 219-224.
19. Mulsch, A., Busse, R., Mordvintcev, P.I., Vanin, A., Nielsen, E.O., Scheel-Kruger, J. and Olesen., S.-P., Nitric oxide promotes seizure activity in kainate-treated rats, NeuroReport, 5 (1994) 2325-2328.
20. O'Dell, T.J., Hawkins, R.D., Kandel, E.R. and Arancio, O., Tests of the roles of two diffusible substances in long-term potentiation, Proc. Natl. Acad. Sci. USA. 88 (1991) 11285-11289.
21. Osonoe, K., Mori, N., Suzuki, K. and Osonoe, M., Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats, Brain Res., 663 (1994) 338-340.
22. Penix, L.P., Davis, W. and Subramaniam, S., Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents, Epilepsy Res., 18 (1994) 177-184.
23. Przegalinski, E., Baran, L. and Siwanowicz, J., The role of nitric oxide in kainate-induced seizures in mice, Neurosci. Lett., 170 (1994) 74-76.
24. Rigaud-Monnet, A.-S., Pinard, E, Borredon, J. and Seylaz, J., Blockade of nitric oxide synthesis inhibits hippocampal hyperemia in kainic acid-induced seizures, J. Cereb. Blood Flow Metab., 14 (1994) 581-590.
25. Rondouin, G., Bockaert, J. and Lerner-Natoli, M., L-Nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats, NeuroReport, 4 (1993) 1187-1190.
26. Rondouin, G., Lerner-Natoli, M., Manzoni, O., Lafon-Cazal, M. and Bockaert, J., A nitric oxide (NO) synthase inhibitor accelerates amygdala kindling, NeuroReport, 3 (1992) 805-808.
27. Rundfeldt, L., Koch, R., Richter, A., Meuissen, M., Gerecke, V. and Loscher, W., Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats, Eur. J. Pharmacol., 274 (1995) 73-81.
28. Starr, M.S. and Starr, B.S., Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol. Biochem. Behav., 45 (1993) 321-325.
29. Wang, Q., Theard, M.A., Pellegrino, D.A., Baughman, V.L., Hoffman, W.E., Albrecht, R.F., Cwik, M., Paulson, O.B. and Lassen., N.A., Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats, Brain Res., 658 (1994) 192-198.